CONMED Corporation
CNMD Healthcare Medical Devices
CONMED Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 5.18% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 11.6%, free cash flow grew 46.0% and total debt fell 5.40%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
Follow CNMD
CONMED Corporation (CNMD) EV/Sales
As of 16 October 2026, CONMED Corporation (CNMD) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from 1.3× (June 2026) to 5.6× (May 2021); the current reading is higher than 7% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.5× | (34.73%) |
| FY2024 | 2.3× | (34.14%) |
| FY2023 | 3.5× | (2.36%) |
| FY2022 | 3.6× | (25.01%) |
| FY2021 | 4.7× | 4.25% |
| FY2020 | 4.6× | 11.22% |
| FY2019 | 4.1× | 56.81% |
| FY2018 | 2.6× | 11.33% |
| FY2017 | 2.3× | 5.35% |
| FY2016 | 2.2× | 13.03% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.3× | (6.70%) |
| Mar 2026 | 1.4× | (6.86%) |
| Dec 2025 | 1.5× | (11.32%) |
| Sep 2025 | 1.7× | (9.14%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ENOV Enovis Corporation compare | 1.0× |
| TNDM Tandem Diabetes Care, Inc. compare | 1.2× |
| CNMD CONMED Corporation | 1.6× |
| BVS Bioventus Inc. compare | 1.9× |
| NVCR NovoCure Limited compare | 2.0× |
| ATEC Alphatec Holdings, Inc. compare | 2.6× |
| AORT Artivion, Inc. compare | 2.9× |
| ESTA Establishment Labs Holdings Inc. compare | 8.1× |
| IRMD iRadimed Corporation compare | 12.4× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)